$0.3700
-0.0254-6.42%
Last update: Nov 12, 9:21 AM
Evogene Ltd
EVGNNASDAQ
Evogene fell 68.1% from $1.24 to $0.40, behind the S&P 500's +11.2%. Its worst day was Nov 5 (−14.0%), and its low came Nov 6 at $0.27.
Nov 12, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.31 beat the $-0.41 estimate on $312,000.00 revenue (est. $650,000.00).
−7.7% · S&P 500 −1.5%
Evogene shares rose 17.1%, while the S&P 500 fell 0.7%.
Story events cover the past 12 months · Times ET
+17.1% · S&P 500 −0.7%
EPS of $-0.61 missed the $-0.26 estimate on $314,000.00 revenue (est. $275,000.00).
−5.9% · S&P 500 −0.6%
EPS of $-0.60 missed the $-0.27 estimate on $334,000.00 revenue (est. $350,000.00).
−3.2% · S&P 500 +1.0%
Evogene shares rose 20.7%, while the S&P 500 rose 0.8%.
+20.7% · S&P 500 +0.8%
Evogene shares rose 21.4%, while the S&P 500 rose 1.8%.
+21.4% · S&P 500 +1.8%
EPS of $-0.13 beat the $-0.27 estimate on $347,000.00 revenue (est. $325,000.00).
+4.0% · S&P 500 −0.7%
Evogene closed at its lowest level of the year, 78.1% below where the year started.
−11.7% · S&P 500 +0.3%
Where it ended: a close of $0.40 on Nov 11, 2026. Up next: Q3 2026 earnings on Nov 19, 2026 (EPS est. $-0.19, revenue est. $366,000.00).
Nothing in the past 12 months.
All EVGN analyst actionsNothing in the past 12 months.
All EVGN dividend historyReplay the year: the line draws itself and stops at each of the 8 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for EVGN and SPY from Benzinga historical bars. Not investment advice.
